Sugi Predict

Sugi Predict / Compounds / SCHEMBL7908206

SCHEMBL7908206

SCHEMBL7908206

Cc1cc(F)c(F)c(F)c1N

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.43
▸ CYP3A4 P08684 2/20 0.43
▸ TSHR P16473 2/20 0.43
▸ TP53 P04637 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ POLB P06746 1/20 0.37
▸ RAPGEF4 Q8WZA2 1/20 0.34
▸ LMNA P02545 1/20 0.33
▸ MAPK1 P28482 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.31
▸ CA12 O43570 1/20 0.31
▸ CA1 P00915 1/20 0.31
▸ CA2 P00918 1/20 0.31
▸ CA7 P43166 1/20 0.31
▸ CA13 Q8N1Q1 1/20 0.31
▸ ACHE P22303 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31569104 0.84 CYP3A4 (0.43) ALDH1A1CYP3A4TSHRTP53TDP1
SCHEMBL8102399 0.82 CYP3A4 (0.42) ALDH1A1CYP3A4TSHRTP53TDP1
SCHEMBL21603389 0.82 ALDH1A1 (0.42) ALDH1A1CYP3A4TSHRTP53TDP1
SCHEMBL29824949 0.82 ALDH1A1 (0.42) ALDH1A1CYP3A4TSHRTP53TDP1
SCHEMBL16553243 0.81 TSHR (0.39) ALDH1A1CYP3A4TSHRTP53TDP1
SCHEMBL1032872 0.80 CA1 (0.40) ALDH1A1CYP3A4TSHRTP53TDP1
SCHEMBL30952527 0.80 CA1 (0.40) ALDH1A1CYP3A4TSHRTP53TDP1
SCHEMBL21852776 0.79 CYP3A4 (0.38) ALDH1A1CYP3A4TSHRTP53TDP1
SCHEMBL22063008 0.78 ALDH1A1 (0.39) ALDH1A1CYP3A4TSHRTP53TDP1
SCHEMBL21603460 0.78 ALDH1A1 (0.39) ALDH1A1CYP3A4TSHRTP53TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118633992-B Aortic dissection distal aneurysm zonal multi-branch stent 上海浦东复旦大学张江科技研究院 2025-02-11 — — CN claimed
CN-118496608-B High-temperature-resistant fluoroelastomer processing aid for slurry polyethylene process and preparation method thereof 稷昶新材料科技(上海)有限公司 2025-02-07 — — CN claimed
CN-118742174-A Perovskite precursor solution, perovskite solar cell and preparation method 天合光能股份有限公司 2024-10-01 — — CN claimed
CN-118633992-A Aortic dissection distal aneurysm zonal multi-branch stent 上海浦东复旦大学张江科技研究院 2024-09-13 — — CN claimed
CN-118496608-A High-temperature-resistant fluoroelastomer processing aid for slurry polyethylene process and preparation method thereof 稷昶新材料科技(上海)有限公司 2024-08-16 — — CN claimed
CN-116986994-A Synthesis method of o-aminotrifluorotoluene 东至德泰精细化工有限公司 2023-11-03 — — CN claimed
CN-113636919-B Method for synthesizing 3-chloro-5-trifluoromethyl trifluoroacetophenone 上海恩氟佳科技有限公司 2023-10-24 — — CN claimed
CN-114230792-A Positive photosensitive polyimide resin, resin composition, and preparation method and application thereof 明士(北京)新材料开发有限公司 2022-03-25 — — CN claimed
CN-120208792-A Preparation process of 2-bromo-4- (perfluoropropane-2-yl) -6- (trifluoromethyl) aniline 大愿健康管理(山东)集团有限公司 2025-06-27 — — CN disclosed
CN-120152951-A Meta-diamide compound and preparation method and application thereof 迈克斯(如东)化工有限公司 2025-06-13 — — CN disclosed
WO-2025077779-A1 META-DIAMIDE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF 迈克斯(如东)化工有限公司 2025-04-17 — — WO disclosed
CN-118633992-B Aortic dissection distal aneurysm zonal multi-branch stent 上海浦东复旦大学张江科技研究院 2025-02-11 — — CN disclosed
CN-119390547-A Preparation method of 1- (3-chloro-5- (trifluoromethyl) phenyl) -2, 2-trifluoro-ethanone 上海皓元医药股份有限公司 2025-02-07 — — CN disclosed
CN-118496608-B High-temperature-resistant fluoroelastomer processing aid for slurry polyethylene process and preparation method thereof 稷昶新材料科技(上海)有限公司 2025-02-07 — — CN disclosed
US-10633338-B2 Binding Function 3 (BF3) site compounds as therapeutics and methods for their use THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2020-04-28 — — US disclosed
US-20190300480-A1 BINDING FUNCTION 3 (BF3) SITE COMPOUNDS AS THERAPEUTICS AND METHODS FOR THEIR USE THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2019-10-03 — — US disclosed
US-10351527-B2 Binding function 3 (BF3) site compounds as therapeutics and methods for their use THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2019-07-16 — — US disclosed
US-20170029372-A1 BINDING FUNCTION 3 (BF3) SITE COMPOUNDS AS THERAPEUTICS AND METHODS FOR THEIR USE THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2017-02-02 — — US disclosed
CN-106216883-A A kind of for Cu Mg Sn Fe composite nano materials laser scaling powder and preparation method thereof 徐州工程学院 2016-12-14 — — CN disclosed
US-6191309-B1 USING A COMPOUND OF FORMULA X2 IN A SOLVENT SELECTED FROM AN ANHYDROUS HALOGENATED HYDROCARBON, A MIXTURE OF WATER AND A HALOGENATED HYDROCARBON AND OPTIONALLY THE COMPOUND ITSELF, TO GIVE HALOGENATED 2-AMINO OR 2-ACETAMIDOTRIFLUOROMETHYLBENZENE RHODIA CHIMIE (FR) 2001-02-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190300480-A1 BINDING FUNCTION 3 (BF3) SITE COMPOUNDS AS THERAPEUTICS AND METHODS FOR THEIR USE KLK3, SHBG, ACP3 ALDH1A1 2387/4885CYP3A4 2750/4885TSHR 3996/4885
US-10633338-B2 Binding Function 3 (BF3) site compounds as therapeutics and methods for their use KLK3, SHBG, ACP3 ALDH1A1 2387/4885CYP3A4 2750/4885TSHR 3996/4885
US-10351527-B2 Binding function 3 (BF3) site compounds as therapeutics and methods for their use KLK3, SHBG, ACP3 ALDH1A1 2387/4885CYP3A4 2750/4885TSHR 3996/4885
US-20170029372-A1 BINDING FUNCTION 3 (BF3) SITE COMPOUNDS AS THERAPEUTICS AND METHODS FOR THEIR USE KLK3, SHBG, ACP3 ALDH1A1 2387/4885CYP3A4 2750/4885TSHR 3996/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.